Skip to content
value.today

MycoMedica Life Sciences, PBC

🇺🇸 Shelton, Washington, USABiotechnologyFounded 2021
Total raised
$23 M
1 round on record
Latest round
$23 M
May 2021
First round on record
May 2021
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of MycoMedica Life Sciences, PBC
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2021$23 MNo. 1$10 to $50 million

MycoMedica Life Sciences, PBC: Raise no. 1, May 2021

Investors in this round

73 investors had bought by the notice of Dec 28, 2021: 73 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$23 M of $23 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Parrish · Executive Officer
  • Paul Stamets · Executive Officer, Director, Promoter
  • Tad Buchanan · Executive Officer, Director
  • James Joaquin · Director
  • Pamela Kryskow · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Does not include $3,432,727.10 sold to 30 investors who reside outside the United States”

Signed by Paul Stamets, President. Newest notice filed Dec 28, 2021 (1 amendment). Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • MycoMedica Life Sciences, PBC chose not to state its revenue in its newest notice of a funding round (Dec 2021).

    SEC Form D · Dec 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Dec 2021

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of MycoMedica Life Sciences, PBC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by MycoMedica Life Sciences, PBC
NameRoleNamed in
John ParrishExecutive officerDec 2021
Paul StametsExecutive officerDec 2021
Tad BuchananExecutive officerDec 2021
James JoaquinDirectorDec 2021
Pamela KryskowDirectorDec 2021
Paul StametsDirectorDec 2021
Tad BuchananDirectorDec 2021
Paul StametsPromoterDec 2021